LSL Pharma Group Inc's market cap is currently ―. The company's EPS TTM is C$-0.003; its P/E ratio is 11.97; LSL Pharma Group Inc is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
